By Amina Niasse NEW YORK, July 23 (Reuters) – Health insurer Cigna said on Thursday that the artificial intelligence tools it is employing to identify patients with chronic or complex conditions will save customers $200 million in medical costs over the next three years. Bryan Holgerson, a president
BEIJING, July 23 (Reuters) – BeOne Medicines announced on Thursday an additional $300 million investment to a manufacturing and R&D facility in New Jersey, bringing total U.S. manufacturing investment to more than $1 billion, it said in a statement. “The expansion will increase BeOne’s production ca
BUDAPEST, July 23 (Reuters) – Hungary’s government will scrap a 5% value-added tax on subscription drugs from September 1, which will cost the budget 7 billion forints ($21.93 million), Prime Minister Peter Magyar said on Thursday. The government is also planning to cut the value-added tax on wood u
By Deena Beasley July 23 (Reuters) – Eli Lilly said on Thursday that two more Phase 3 trials of its experimental obesity drug retatrutide showed positive results and it plans to submit an application to the U.S. Food and Drug Administration in the first quarter of next year. Retatrutide is designed
By Siddhi Mahatole July 23 (Reuters) – West Pharmaceutical Services raised its annual profit and revenue forecasts on Thursday as strong demand for components used in injectable drugs, including diabetes and obesity treatments, helped it beat second-quarter estimates. Shares of the medical equipment
By Puyaan Singh and Kunal Das July 23 (Reuters) – Thermo Fisher Scientific raised its annual profit forecast after beating Wall Street estimates for second-quarter results on Thursday, as improving customer demand lifted sales across all its business segments, sending shares up 10%. The life science
By Christy Santhosh July 23 (Reuters) – Shares of health insurer Molina Healthcare fell 9% in premarket trading on Thursday as concerns about the company’s Obamacare and Medicaid businesses weighed on its second-quarter results. The company late on Wednesday posted quarterly profit and revenue that
By Amina Niasse July 23 – Hims & Hers Health is set to tap what analysts estimate could be a multi-billion-dollar market for peptides if U.S. regulators loosen manufacturing restrictions. Hims, primarily known for its personalized treatments of conditions ranging from hair loss to acne, is eyeing pe
July 23 (Reuters) – Ebola has now killed more than 1,000 people in the Democratic Republic of Congo, official figures show, as medics struggle to contain an outbreak amid militant violence, attacks on clinics and widespread shortages. The number of confirmed Ebola cases has increased to 2,536, Congo
JAKARTA, July 23 (Reuters) – Indonesia’s tobacco groups pushed back on Thursday against government plans for tougher regulations on cigarette making and marketing, saying the $40-billion industry will be harmed by proposed limits on nicotine and tar content, among others. The regulations set to be i
July 23 (Reuters) – India’s Cipla posted a bigger-than-expected fall in first-quarter profit on Thursday, logging its third straight quarterly decline as muted sales of a generic cancer drug and U.S. supply disruptions related to tumor treatment lanreotide weighed on results. The drugmaker also appo
HETAUDA, Nepal (AP) — Associated Press reporter Kristen Gelineau, who has been covering the impact of U.S. foreign aid cuts, reported and wrote the story of how the cuts have prompted scores of unemployed aid workers in Nepal to turn to sex work to survive. The workers are among 280,000 worldwide wh
HETAUDA, Nepal (AP) — For years, aid workers in central Nepal visited the shadowy spot alongside a darkened highway where transgender sex workers gather each night, offering them free HIV tests and counseling. Today, those aid workers still visit this spot — but this time, as sex workers themselves.
HETAUDA, Nepal (AP) — The United States’ decision to slash its foreign aid program has been devastating for scores of aid workers left jobless by the funding cuts, contributing to poverty, violence and an increased risk of HIV transmission, The Associated Press has found. When U.S. President Donald
HETAUDA, Nepal (AP) — She paces the side of the darkened highway in central Nepal, just enough light from the trucks roaring past to illuminate her painted face to the men rolling in on rickshaws and motorbikes. She knows that every stranger who pays for her body could end her life. But she also kno
By Laurie Chen SHANGHAI, July 23 (Reuters) – Hong Kong-listed Insilico Medicine has cut drug development timelines to about one year by combining AI with its China research ecosystem, its CEO said, giving it an edge over traditional Western pharmaceutical giants. Its strategy highlights how China’s
By Lucie Barbier July 23 (Reuters) – Belgian-Dutch immunology company argenx said on Thursday that global sales of its lead drug Vyvgart jumped in the second quarter of 2026 from a year earlier, sending its shares higher. Vyvgart sales came in at $1.516 billion in the second quarter, up 60% from $94
July 23 (Reuters) – German biopharma supplier Sartorius reported half-year earnings slightly above market expectations on Thursday, citing stable recurring business and the effect of U.S. tariff refunds. The company reported an underlying earnings margin before interest, taxes, depreciation and amor
July 23 (Reuters) – Shares of Dr Reddy’s Laboratories declined 4.4% on Thursday after brokerages cut their earnings forecasts for the Indian drugmaker after weaker-than-expected quarterly results and semaglutide supply disruptions. The stock was trading at 1,130 rupees, its lowest in over one year,
WASHINGTON (AP) — Defense Secretary Pete Hegseth’s new initiative to test and treat troops for low testosterone has prompted a federal judge to question the differences between that kind of testosterone replacement therapy and hormone treatment for transgender men in the military. U.S. District Judg
By Nancy Lapid July 22 (Reuters) – The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest. At two or more years after starting treatment, the odds of a new diagnosis of alopecia in GLP-1 users were 37% hi
By Padmanabhan Ananthan July 22 (Reuters) – Molina Healthcare raised its annual profit forecast on Wednesday after posting second-quarter profit and revenue that beat Wall Street estimates, helped by stronger-than-expected performance in its Medicaid and Medicare businesses. The health insurer now e
July 22 (Reuters) – Pfizer said on Wednesday the U.S. Food and Drug Administration had granted priority review to its application seeking expanded approval for its prostate cancer treatment combination. The company had sought expanded approval to use a combination of two approved drugs — branded as
By Dietrich Knauth July 22 (Reuters) – A federal judge cast doubt on Wednesday on claims by approximately 69,000 people alleging that Johnson & Johnson’s baby powder and other talc products caused ovarian cancer, saying plaintiffs must provide more specific evidence or risk having their lawsuits dis
July 22 (Reuters) – The U.S. FDA has said it is investigating a new outbreak of cyclosporiasis, with 72 cases tied to an as-yet-unidentified source. The agency’s announcement on Wednesday adds to the growing number of cyclosporiasis cases reported across the U.S. Midwest, including Michigan and four
July 22 (Reuters) – The generic drug market still faces structural and purchasing hurdles despite strong U.S. growth, an industry group noted on Wednesday, after President Donald Trump said imported generic medicines would face up to 200% tariffs after two years. “Our industry has grown significantl
By Padmanabhan Ananthan and Bhanvi Satija July 22 (Reuters) – GSK said on Wednesday the U.S. FDA approved its drug to treat a form of lung cancer, nearly two months after the British drugmaker acquired the treatment as part of a historic $10.6 billion deal. The approval, which marks GSK’s entry into
PARIS, July 22 (Reuters) – France recorded 5,764 excess deaths between June 17 and July 2 when the country was hit by heatwaves, the national health agency reported on Wednesday. Health Minister Stephanie Rist had originally estimated the excess deaths in late June at 2,025. • The count, which inclu
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays) By Nancy Lapid July 22 (Reuters) – We also have some data from researchers who compared injuries in riders of e-bikes vs. traditional bicycles. (Guess which injuries were worse?) N
By Sneha S K and Sriparna Roy July 22 (Reuters) – U.S. FDA advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if regulators decline to expand access, industry participants say consumer demand is likely to remain strong. The review comes as
